Committees

Return to Committees page

Rome Severity Commitee Report

Rome working group on severity in the functional GI disorders

Measuring severity in functional GI disorders (FGIDs) is extremely important since it can guide diagnostic evaluation, risk assessment, and treatment decisions. However, there has been a lack of consensus regarding severity in irritable bowel syndrome (IBS) and other FGIDs. In late 2005, the Rome Foundation assembled a working group to develop guidelines for severity assessment in FGID. This committee is comprised of members with different areas of expertise but with a mutual interest in severity and/or health outcomes assessment. The committee produced a report that has been published in the The American Journal of Gastroenterology.

Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report

Douglas A. Drossman, MD, L. Chang, MD, N. Bellamy, DSc, H.E. Gallo-Torres, MD, A. Lembo, MD, F. Mearin, MD, N.J. Norton and P. Whorwell, MD, FRCP.
The American Journal of Gastroenterology

Committee Composition

Douglas A. Drossman, MD, Chair
UNC Center for Functional GI & Motility Disorders
Chapel Hill, NC, USA

Nicholas Bellamy, MD, MSc, MBA, DSc, FRCP(C), FRCP, (Glas,Edin), FACP, FRACP
The University of Queensland
Brisbane, Qld, AUSTRALIA

Tony Lembo, MD
Beth Israel DeaConess Medical Center
Boston, MA, USA

Nancy Norton, BS
International Foundation for Functional Gastrointestinal Disorders
Milwaukee, WI, USA

Lin Chang, MD, Co-Chair
UCLA CNS: Center for Neurovisceral Sciences & Women's Health
Los Angeles, CA, USA

Hugo E. Gallo-Torres, MD, PhD, PNS
US Food and Drug Administration
Rockville, MD, USA

Fermín Mearin, MD
Institute of Functional and Motor Digestive Disorders
Centro Médico Teknon
Barcelona, SPAIN

Peter Whorwell, PhD
Wythenshawe Hospital
Manchester, UK